![](/wp-content/themes/yootheme/cache/e4/febs14532-toc-0001-m-e4afd479.png)
Dr. Mordechai Gerlic’s Paper on the Cover of The FEBS Journal
February 11, 2019 |
IL-33 is a pro-inflammatory cytokine that plays a role in a range of inflammatory diseases.
To date, the mechanism underlying its release in cells is not fully understood.
A recent work led by MD/PhD student Inabr Shlomovitz and Dr. Motti Gerlic demonstrate that necroptosis, a form of cell death, triggers the release of IL-33 in its bioactive form. Inhibition of necroptosis in an Aspergillus allergic asthma model results in reduced inflammation, providing in vivo evidence that necroptosis contributes to IL-33-associated inflammatory disease.
Related posts
![](/wp-content/themes/yootheme/cache/01/satchi_fainaro_skincancer_580-01fc78da.webp)
![](/wp-content/themes/yootheme/cache/c7/Ronit-Satchi-Fainaru_4_0-c71955ce.webp)
![](/wp-content/themes/yootheme/cache/b2/medicine-shot-580_0-1-b246c08a.jpeg)
![](/wp-content/themes/yootheme/cache/51/Nanodrug-Enables-2-in-1-Attack-on-Cancer-5149faf3.jpeg)
![](/wp-content/themes/yootheme/cache/ff/heart-research-580_0-ff38acc4.webp)
![](/wp-content/themes/yootheme/cache/39/1-Prof.-Tal-Dvir-Credit-Israel-Hadari-580--39f4fa71.jpeg)
TAU Breakthrough Offers New Hope to Help People With Paralysis Walk Again
![](/wp-content/themes/yootheme/cache/a2/Prof.-Chaim-Pick-Ph.D.-student-Meirav-Har-Even-Kerzhner-580-a2401043.jpeg)
![](/wp-content/themes/yootheme/cache/0f/Image-580-0fdd7159.jpeg)